Earnings History Data for Structure Therapeutics Inc. (GPCR) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Structure Therapeutics Inc.
Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-08-2024 | PM | GPCR | Structure Therapeutics Inc. | 1,640 | -0.18 | -0.23 | -0.20 | Structure Therapeutics reports Q2 results [8/9/2024 6:31 AM] |
33.81 | -0.68 (-1.97%) |
35.54 | 1.05 (3.04%) |
25.57 - 75.02 | 711,476 | 620,000 | 231 | ||
| 09-05-2024 | PM | GPCR | Structure Therapeutics Inc. | 1,830 | -0.19 | -0.21 | -0.25 | Structure Therapeutics reports Q1 results [5/10/2024 7:22 AM] |
36.07 | -2.58 (-6.68%) |
38.65 | 0.0 (0.00%) |
21.79 - 75.02 | 501,663 | 500,000 | 3,645 | ||
| 08-03-2024 | PM | GPCR | Structure Therapeutics Inc. Sponsored ADR | 1,853 | -0.17 | -0.21 | 0.00 | 37.12 | 1.11 (3.07%) |
0.0 | 0.0 (0.00%) |
21.12 - 75.02 | 989,058 | 790,000 | 0 | |||
|
|
||||||||||||||||||
| 14-11-2023 | AH | GPCR | Structure Therapeutics Inc. Sponsored ADR | 2,100 | -0.21 | -0.22 | 0.00 | Structure Therapeutics GAAP EPS of -$0.21 beats by $0.01 [11/14/2023 5:13 PM] |
47.93 | -5.66 (-10.56%) |
54.56 | 0.97 (1.81%) |
20.80 - 75.02 | 1,082,324 | 710,000 | 638 | ||
| 10-08-2023 | AH | GPCR | Structure Therapeutics Inc. Sponsored ADR | 1,148 | -0.20 | -0.19 | 0.00 | 27.63 | -1.72 (-5.86%) |
29.35 | 0.0 (0.00%) |
20.80 - 42.55 | 512,921 | 860,000 | 273 | |||
|
|
||||||||||||||||||
| 11-05-2023 | AH | After the close (May 11) |
GPCR | Structure Therapeutics Inc. Sponsored ADR | 0.00 | -0.25 | -0.34 | 0.00 | Structure Therapeutics GAAP EPS of -$0.25 beats by $0.09 [5/11/2023 5:48 PM] |
26.58 | 1.58 (6.32%) |
0.0 | 0.0 (0.00%) |
20.80 - 30.00 | 55,699 | 50,000 | 0 | |